Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Astellas Venture Fund I L.P. — Epizyme, Inc. insider: 3 transactions · InsiderLens

Home / Insiders / Astellas Venture Fund I L.P.

Astellas Venture Fund I L.P.

10% owner at Epizyme, Inc. · on record since May 30, 2013

Insider trading activity of Astellas Venture Fund I L.P.

Transactions on record: 3; since Jun 6, 2013

Open-market buys: 1; $230K

Open-market sells: 0

Companies traded: 1; last filing Jun 6, 2013

Figures computed from official regulatory filings — methodology.

Companies where Astellas Venture Fund I L.P. has traded

Epizyme, Inc.3 tx · $230K · Jun 6, 2013

Track record of Astellas Venture Fund I L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Astellas Venture Fund I L.P.

Co-insiders of Astellas Venture Fund I L.P.

Agarwal ShefaliEpizyme, Inc.
Allen Andrew REpizyme, Inc.
AMGEN INCEpizyme, Inc.
Amgen Ventures LLCEpizyme, Inc.
Astellas Venture Management LLCEpizyme, Inc.
BARRETT M JAMESEpizyme, Inc.
BARRIS PETER JEpizyme, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BASKETT FORESTEpizyme, Inc.

BATE KENNETHEpizyme, Inc.

Bay City Capital Fund V Co-Investment Fund LPEpizyme, Inc.

Bay City Capital Fund V, L.P.Epizyme, Inc.

BAY CITY CAPITAL LLCEpizyme, Inc.

Bay City Capital Management V LLCEpizyme, Inc.

Bazemore Robert BEpizyme, Inc.

Beaulieu JosephEpizyme, Inc.

BEVERIDGE, ROY AEpizyme, Inc.

Bogle Grant C.Epizyme, Inc.

CELGENE CORP /DE/Epizyme, Inc.

Celgene European Investment Co LLCEpizyme, Inc.

Conroy Kevin TEpizyme, Inc.

Copeland Robert AEpizyme, Inc.

Daniel Thomas OEpizyme, Inc.

DRANT RYAN DEpizyme, Inc.

EVNIN LUKEEpizyme, Inc.

Fleming SuzanneEpizyme, Inc.

Foley ToddEpizyme, Inc.

GADICKE ANSBERTEpizyme, Inc.

Garbacz StephenEpizyme, Inc.

Giordano Michael FEpizyme, Inc.

GOLDFISCHER CARLEpizyme, Inc.

Gould Robert JEpizyme, Inc.

Graf Susan EEpizyme, Inc.

Hedrick EricEpizyme, Inc.

Ho Peter Tai-ChingEpizyme, Inc.

Horvitz H RobertEpizyme, Inc.

KAILIAN VAUGHN MEpizyme, Inc.

KERINS PATRICK JEpizyme, Inc.

KLEINER PERKINS CAUFIELD & BYERS XIII, LLCEpizyme, Inc.

KOLLURI KRISHNA KITTUEpizyme, Inc.

Korn JeraldEpizyme, Inc.

KPCB XIII Associates, LLCEpizyme, Inc.

Kutok JefferyEpizyme, Inc.

Legorreta Pablo G.Epizyme, Inc.

MOTT DAVID MEpizyme, Inc.

MPM Asset Management Investors BV4 LLCEpizyme, Inc.

MPM BioVentures IV GmbH & Co. Beteiligungs KGEpizyme, Inc.

MPM BioVentures IV GP LLCEpizyme, Inc.

MPM BioVentures IV LLCEpizyme, Inc.

MPM BioVentures IV QP LPEpizyme, Inc.

MPM BioVentures IV Strategic Fund, L.P.Epizyme, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Epizyme, Inc.	Jun 6, 2013	Other	634,920	—	—	SEC
Epizyme, Inc.	Jun 6, 2013	Buy	15,333	15.00 USD	$230K	SEC
Epizyme, Inc.	Jun 6, 2013	OtherD	-1,904,762	0.00 USD	$0	SEC